Abstract
Plants belonging to Withania genus are well-known medicinal plants and are commonly used as herbal medicine in the Ayurvedic health system. These plants belong to the family Solanaceae and comprise of 23 known species distributed in North Africa, the Middle East, Asia, the Mediterranean, and the Canary Islands. However, only six species, namely, Withania somnifera (L.) Dunal, Withania coagulans (Stocks) Dunal, Withania adpressa Coss, Withania aristata (Aiton) Pauquy, Withania frutescens (L.) Pauquy, and Withania obtusifolia Täckh, are extensively investigated with regard to their pharmacological properties and bioactive constituents. Therefore, in this chapter, the traditional uses of the six Withania species and the pharmacological validations of the plants and plant-derived constituents are discussed. Applications of the bioactive constituents in drug discovery are explained by discussing the semisynthetic modifications and structure-activity relationships.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdeljebbar LH, Benjouad A, Morjani H, Merghoub N, El Haddar S, Humam M et al (2009) Antiproliferative effects of Withanolides from Withania adpressa. Therapie 64(2):121–127
Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D et al (2010) Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril 94(3):989–996
Ahmad R, Fatima A, Srivastava AN, Khan MA (2017) Evaluation of apoptotic activity of Withania coagulans methanolic extract against human breast cancer and Vero cell lines. J Ayurveda Integr Med 8:177e183
Akanksha, Srivastava AK, Maurya R (2010) Antihyperglycemic activity of compounds isolated from Indian medicinal plants. Ind J Exp Biol 48:294–298
Alali FQ, Amrine CSM, El-Elimat T, Alkofahi A, Tawaha K, Gharaibah M et al (2014) Bioactive withanolides from Withania obtusifolia. Phytochem Lett 9:96–101
Andallu B, Radhika B (2000) Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol 38(6):607–609
Askarne L, Talibi I, Boubaker H, Boudyach EH, Msanda F, Saadi B et al (2012) In vitro and in vivo antifungal activity of several Moroccan plants against Penicillium italicum, the causal agent of citrus blue mold. Crop Prot 40:53–58
Baitharu I, Jain V, Deep SN, Hota KB, Hota SK, Prasad D et al (2013) Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. J Ethnopharmacol 145(2):431–441
Bakrim WB, El Bouzidi L, Nuzillard J-M, Cretton S, Saraux N, Monteillier A et al (2018) Bioactive metabolites from the leaves of Withania adpressa. Pharm Biol 56(1):505–510
Benjumea D, Martín-Herrera D, Abdala S, Gutiérrez-Luis J, Quinones W, Cardona D et al (2009) Withanolides from Whitania aristata and their diuretic activity. J Ethnopharmacol 123:351–355
Bhat J, Damle A, Vaishnav PP, Albers R, Joshi M, Banerjee G (2010) In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. Phytother Res 24(1):129–135
Bouzidi LE, Mahiou-Leddet V, Sok-S B, Larhsini M, Abbad A, Markouk M et al (2013) Cytotoxic withanolides from the leaves of Moroccan Withania frutescens. Pharm Biol 51(8):1040–1046
Budhiraja RD, Bala S, Garg KN (1977) Pharmacological investigations on fruits of Withania coagulans Dunal. Planta Med 32:154–157
Budhiraja RD, Sudhir S, Garg KN (1983) Cardiovascular effects of a withanolide from Withania coagulans, dunal fruits. Ind J Physiol Pharmacol 27(2):129–134
Candelario M, Cuellar E, Reyes-Ruiz JM, Darabedian N, Feimeng Z, Miledi R et al (2015) Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. J Ethnopharmacol 171:264–272
Chandrasekhar K, Kapoor J, Anishetty S (2012) A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 34(3):255–262
Chang E, Pohling C, Natarajan A, Witney TH, Kaur J, Xu L et al (2016) AshwaMAX and Withaferin a inhibits gliomas in cellular and murine orthotopic models. J Neuro-Oncol 126:253–264
Chen L-X, He H, Qiu F (2011) Natural withanolides: an overview. Nat Prod Rep 28:705–740
Choudhary MI, Hussain S, Yousuf S, Dar A, Mudassar A-u-R (2010) Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line. Phytochemistry 71:2205–2209
Choudhary MI, Nawaz SA, Zaheer-ul-Haq LMA, Ghayur MN, Jalil S et al (2005) Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem Biophys Res Commun 334:276–287
Choudhary MI, Yousuf S, Nawaz SA, Ahmed S, Atta-ur-Rahman (2004) Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull 52(11):1358–1361
Dabheliya J, Khan SA, Joshipura M, Vasoya M, Patel S, Vijaya S (2010) Diuretic potential of aqueous extract of fruits of W. coagulans Dunal in experimental rats. Int J Pharm Pharm Sci 2(4):51–53
Datta A, Bagchi C, Das S, Mitra A, Pati AD, Tripathi SK (2013) Antidiabetic and antihyperlipidemic activity of hydroalcoholic extract of Withania coagulans Dunal dried fruit in experimental rat models. J Ayurveda Integr Med 4:99–106
Glotter E (1991) Withanolides and related ergostane-type steroids. Nat Prod Rep 8(4):415–440
Gupta A, Mahdi AA, Shukla KK, Ahmad MK, Bansal N, Sankhwar P et al (2013) Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: a proton NMR study at 800MHz. J Ethnopharmacol 149:208–214
Hemalatha S, Wahi AK, Singh PN, Chansouria JPN (2004) Hypoglycemic activity of Withania coagulans Dunal in streptozotocin induced diabetic rats. J Ethnopharmacol 93:261–264
Hemalatha S, Wahi AK, Singh PN, Chansuria JPN (2006) Hypolipidemic activity of aqueous extract of Withania coagulans Dunal in albino rats. Phytother Res 20:614–617
Hoda Q, Ahmad S, Akhtar M, Najmi AK, Pillai K, Ahmad SJ (2010) Antihyperglycaemic and antihyperlipidaemic effect of poly-constituents, in aqueous and chloroform extracts, of Withania coagulans Dunal. In experimental type 2 diabetes mellitus in rats. Hum Exp Toxicol 29(8):653–658
Huang C-F, Ma L, Sun L-J, Ali M, Arfan M, Liu J-W et al (2009) Immunosuppressive Withanolides from Withania coagulans. Chem Biodivers 6:1415–1426
Ihsan-ul-Haq YUJ, Chai X, Park E-J, Kondratyuk TP, Simmons CJ et al (2013) Biologically active withanolides from Withania coagulans. J Nat Prod 76:22–28
Jaiswal D, Rai PK, Watal G (2009) Antidiabetic effect of Withania coagulans in experimental rats. Ind J Clin Biochem 24(1):88–93
Jayaprakasam B, Nair MG (2003) Cyclooxygenase-2 enzyme inhibitory withanolides from Withania somnifera leaves. Tetrahedron 59:841–849
Jonathan G, Rivka R, Avinoam S, Lumir H, Nirit B (2015) Hypoglycemic activity of withanolides and elicitated Withania somnifera. Phytochemistry 116:283–289
Joshi P, Misra L, Siddique AA, Srivastava M, Kumar S, Darokar MP (2014) Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera. Steroids 79:19–27
Kaur N, Niazi J, Bains R (2013) A review on pharmacological profile of Withania somnifera (Ashwagandha). Res Rev J Bot Sci 2(4):6–14
Khan MA, Subramaneyaan M, Arora VK, Banerjee BD, Ahmed RS (2015) Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats. J Complement Integr Med 12(2):117–125
Khazal KF, Hill DL, Grubbs CJ (2014) Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice. Anticancer Res 34:6327–6332
Khodaei M, Jafari M, Noori M (2012) Remedial use of withanolides from Withania coagulans (stocks) Dunal. Adv Life Sci 2(1):6–19
Kurapati KRV, Atluri VSR, Samikkannu T, Nair MPN (2013) Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8(10):e77624
Liffert R, Hoecker J, Jana CK, Woods TM, Burch P, Jessen HJ et al (2013) Withanolide a: synthesis and structural requirements for neurite outgrowth. Chem Sci 4:2851–2857
LLanos GG, Araujo LM, Jiménez IA, Moujir LM, Bazzocchi IL (2012) Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells. Eur J Med Chem 54:499–511
LLanos GG, Araujo LM, Jiménez IA, Moujir LM, Vázquez JT, Bazzocchi IL (2010) Withanolides from Withania aristata and their cytotoxic activity. Steroids 75:974–981
Mahdi AA, Shukla KK, Ahmad MK, Rajender S, Shankhwar SN, Singh V et al (2011) Withania somnifera improves semen quality in stress-related male fertility. Evid Based Complement Alternat Med 2011:576962
Manchanda S, Mishra R, Singh R, Kaur T, Kaur G (2017) Aqueous leaf extract of Withania somnifera as a potential neuroprotective agent in sleep-deprived rats: a mechanistic study. Mol Neurobiol 54(4):3050–3061
Maqsood M, Qureshi R, Ikram M, Ahmad M, Jabeen B, Asi MR et al (2018) In vitro anticancer activities of Withania coagulans against HeLa, MCF-7, RD, RG2, and INS-1 cancer cells and phytochemical analysis. Integr Med Res 7:184–191
Martin-Herrera D, Abdala S, Benjumea D, Perez-Paz P (2007) Diuretic activity of Withania aristata: an endemic Canary Island species. J Ethnopharmacol 113:487–491
Mathur D, Agrawal RC (2011) Evaluation of in vivo antimutagenic potential of fruits extracts of Withania coagulans. Der Pharma Chemica 3(4):373–376
Matsuda H, Murakami T, Kishi A, Yoshikawa M (2001) Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated Guinea-pig ileum. Bioorg Med Chem 9:1499–1507
Maurya R, Akanksha J, Singh AB, Srivastava AK (2008) Coagulanolide, a withanolide from Withania coagulans fruits and antihyperglycemic activity. Bioorg Med Chem Lett 18:6534–6537
Mikolai J, Erlandsen A, Murison A, Brown KA, Gregory WL, Raman-Caplan P et al (2009) In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytes. J Altern Complement Med 15(4):423–430
Mirjalili HM, Fakhr-Tabatabaei SM, Bonfill M, Alizadeh H, Cusido RM, Ghassempour A et al (2009) Morphology and withanolide production of Withania coagulans hairy root cultures. Eng Life Sci 9(3):197–204
Montilla MP, Cabo J, Navarro MC, Risco S, Jimknez J (1990) The protective and curative action of Withania frutescens leaf extract against CCl4-induced hepatotoxicity. Phytother Res 4(6):212–215
Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, DeWitt DL, Holmes D et al (2009) Withanolide sulfoxide from Ashwagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res 22:987–992
Muralikrishnan G, Dinda AK, Shakeel F (2010) Immunological investigations immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Investig 39:688–698
Nishikawa Y, Okuzaki D, Fukushima K, Mukai S, Ohno S, Ozaki Y et al (2015) Withaferin a induces cell death selectively in androgen-independent prostate cancer cells but not in normal fibroblast cells. PLoS One 10(7):e0134137
Noshahr ZS, Shahraki MR, Ahmadvand H, Nourabadi D, Nakhaei A (2015) Protective effects of Withania somnifera root on inflammatory markers and insulin resistance in fructose-fed rats. Rep Biochem Mol Biol 3(2):62–67
Orrù A, Casu MA, Tambaro S, Marchese G, Casu G, Ruiu S (2016) Withania somnifera (L.) Dunal root extract alleviates formalin-induced nociception in mice: involvement of the opioidergic system. Behav Pharmacol 27(1):57–68
Parker WB, Shaddix SC, Rose LM, Shewach DS, Hertel LW, Secrist JA III et al (1999) Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro-β-D-ribofuranosyl)adenine in CEM cells. Mol Pharmacol 55:515–520
Pingali U, Pilli R, Fatima N (2014) Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharm Res 6(1):12–18
Piouswatson, 2008. Ashwagandha roots. https://commons.wikimedia.org/wiki/File:Aswagandhaherb11.jpg. Public Domain. Accessed Aug 2019
Pramanick DD, Srivastava SK (2015) Pharmacognostic evaluation of Withania coagulans Dunal (Solanaceae) - an important ethnomedicinal plant. Biosci Discov 6(1):06–13
Prasad SK, Kumar R, Patel DK, Hemalatha S (2010) Wound healing activity of Withania coagulans in streptozotocin-induced diabetic rats. Pharm Biol 48(12):1397–1404
Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG et al (2012) Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. J Ayurveda Integr Med 3(3):111–114
Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D (2006) Stabilization of membrane bound enzyme profiles and lipid peroxidation by Withania somnifera along with paclitaxel on benzo(a)pyrene induced experimental lung cancer. Mol Cell Biochem 292:13–17
Sharma S, Joshi A, Hemalatha S (2017) Protective effect of Withania coagulans fruit extract on cisplatin-induced nephrotoxicity in rats. Pharm Res 9(4):354–361
Soman S, Korah PK, Jayanarayanan S, Mathew J, Paulose CS (2012) Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide a. Neurochem Res 37:1915–1927
Spritzler F (2018) 12 Proven health benefits of Ashwagandha. Healthline.com (https://www.healthline.com/nutrition/12-proven-ashwagandha-benefits)
Subbaraju GV, Vanisree M, Rao CV, Sivaramakrishna C, Sridhar P, Jayaprakasam B et al (2006) Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J Nat Prod 69:1790–1792
Sudhanshu MS, Rao N, Menghani E (2012) Phytochemical and antimicrobial activity of Withania coagulans (stocks) Dunal (fruit). Int J Pharm Pharm Sci 4(4):387–389
Takechi T, Uchida J, Fujioka A, Fukushima M (1997) Enhancing 5-fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with uracil in human tumor cells. Int J Oncol 11:1041–1044
Thedford R, Leyimu EO, Thornton DL, Mehta R (1989) Cytotoxicity of N6-cycloalkylated adenine and adenosine analogs to mouse hepatoma cells. Expl Cell Biol 57:53–59
Umadevi M, Rajeswari R, Rahale CS, Selvavenkadesh S, Pushpa R, Sampath KP (2012) Traditional and medicinal uses of Withania somnifera. Pharma Innov 1(9):102–110
Visavadiya NP, Narasimhacharya AV (2007) Hypocholesteremic and antioxidant effects of Withania somnifera (Dunal) in hypercholesteremic rats. Phytomedicine 14(2–3):136–142
Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S (2015) Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr 12:43
Wijeratne EMK, Xu Y, Scherz-Shouval R, Marron MT, Rocha DD, Liu MX et al (2014) Structure−activity relationships for withanolides as inducers of the cellular heat-shock response. J Med Chem 57:2851–2863
Xu Y, Gao S, Bunting DP, Gunatilaka AAL (2011) Unusual withanolides from aeroponically grown Withania somnifera. Phytochemistry 72:518–522
Xu Y, Marron MT, Seddon E, McLaughlin SP, Ray DT, Whitesell L et al (2009) 2,3-Dihydrowithaferin A-3β-O-sulfate, a new potential prodrug of withaferin a from aeroponically grown Withania somnifera. Bioorg Med Chem 17:2210–2214
Zhao J, Nakamura N, Hattori M, Kuboyama T, Tohda C, Komatsu K (2002) Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull 50(6):760–765
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Verma, S., Lall, N., Meyer, D. (2021). A Wonder Plant Withania: Pharmacological and Chemical Perspectives. In: Mandal, S.C., Chakraborty, R., Sen, S. (eds) Evidence Based Validation of Traditional Medicines. Springer, Singapore. https://doi.org/10.1007/978-981-15-8127-4_41
Download citation
DOI: https://doi.org/10.1007/978-981-15-8127-4_41
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-8126-7
Online ISBN: 978-981-15-8127-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)